Ketotifen does not inhibit asthmatic reactions induced by toluene di‐isocyanate in sensitized subjects

L. TOSSIN, P. CHIESURA‐CORONA, Leonardo M. Fabbri, Nicoletta De Marzo, G Picotti, S. Crescioli, Cristina E. Mapp

Clinical & Experimental Allergy · 1989 · 10 citations · 22 references

DOIFull text

Open access

Concepts

Abstract

In order to determine whether treatment with ketotifen inhibits asthmatic reactions induced by toluene di-isocyanate (TDI), we studied six sensitized subjects with previously demonstrated dual or late asthmatic reaction after inhalation challenge with TDI. Ketotifen (1 mg b.i.d., orally) or placebo was administered for 7 days to the examined subjects, according to a double-blind, cross-over, placebo-controlled study design. When the subjects were treated with either ketotifen or placebo, FEV1 markedly decreased after exposure to TDI. These results suggest that the anti-asthmatic agent ketotifen is not effective in TDI-induced asthma and suggest that it should not be used in the prophylaxis of asthmatic reactions induced by TDI in sensitized subjects.

References

22